Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
544611-BOM
544611-BOM

Mahamaya Lifesciences Ltd.

BSE: 544611
SME
Sector: Chemicals
185.35+2.3 (+1.28%)
9 Sep, 12:00 AM

Stock Scores

Quality Score

21.7 / 100

Value Score

43.0 / 100

Price Momentum Score

48.7 / 100

QVM Score

22.8 / 100

Key Metrics

Market Cap
433.81
P/E (TTM)
26.25
P/B
3.56
P/S (TTM)
1.32
EV/EBITDA
14.48
CAPE (5Y)
49.12
ROE (TTM)
19.29
ROCE (TTM)
19.54
ROA (TTM)
6.63
Avg 3Y ROE
26.04
Earnings 3Y CAGR
73.23
Sales 3Y CAGR
33.87
Sales 5Y CAGR
23.71
Debt/Equity
0.74
Consensus TP
-
Strong Buy %
-
Promoter Holding
56.35
Pledged %
0.00

Share Price

Track Mahamaya Lifesciences Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 1.84 %
Low
176.0
High
193.0
1 Month returns: 9.13 %
Low
175.0
High
204.0
1 Year returns: –
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Mahamaya Lifesciences Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Mahamaya Lifesciences Ltd. Shareholding Pattern

Quarterly breakdown of Mahamaya Lifesciences Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Mahamaya Lifesciences Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Mahamaya Lifesciences Ltd.?
The current share price of Mahamaya Lifesciences Ltd. is ₹ 185.35 as of 9 Sep 2026.
What is the market capitalisation of Mahamaya Lifesciences Ltd.?
The market capitalisation of Mahamaya Lifesciences Ltd. stands at ₹ 433.81 Cr.
What is the PE ratio of Mahamaya Lifesciences Ltd.?
The Price-to-Earnings (PE) ratio of Mahamaya Lifesciences Ltd. is 26.25 as of the latest trailing twelve months data.
What is the ROE and ROCE of Mahamaya Lifesciences Ltd.?
Mahamaya Lifesciences Ltd. has a Return on Equity (ROE) of 19.29% and a Return on Capital Employed (ROCE) of 19.54% as per the latest financial reports.
What is the 52-week high and low of Mahamaya Lifesciences Ltd.?
The 52-week high of Mahamaya Lifesciences Ltd. is - and the 52-week low is -.
What is the dividend yield of Mahamaya Lifesciences Ltd.?
The dividend yield of Mahamaya Lifesciences Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Mahamaya Lifesciences Ltd.?
Foreign Institutional Investors (FII) hold 4.77%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 13.66% of Mahamaya Lifesciences Ltd. shares.
What sector does Mahamaya Lifesciences Ltd. belong to?
Mahamaya Lifesciences Ltd. operates in the Chemicals sector.
What is the beta of Mahamaya Lifesciences Ltd.?
The beta of Mahamaya Lifesciences Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of Mahamaya Lifesciences Ltd.?
The 14-day Relative Strength Index (RSI) of Mahamaya Lifesciences Ltd. is 53.29, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.